Novonesis is a global leader in enzyme- and microbe-based 'biosolutions,' formed in 2024 by the merger of Novozymes and Chr. Hansen. Enzymes cut chemical and resource use—cleaning at lower temperatures with fewer chemicals in detergents, raising crop yields while reducing land, pesticide and plastic use in agriculture, and preventing food waste. The former Novozymes cut its own emissions 63% versus 2018 and was among the first companies in the world to have a net-zero target validated by the SBTi. As of 2025, over 80% of its sales and innovation pipeline align with at least one of six selected SDGs.
●●● high
There is no confirmed −; independently verified + decide the position (B). No unreachable strike-through.= non-additive meter
Novonesis: Enzymes—biosolutions that cut chemical and resource use. The letter is B; certainty is high. Unconfirmed concerns are placed under “Watching.” (As of 2026-Q3; estimate based on public information.)
Main narrative
One person’s story (N1)
+ A single story
Cleaning, agriculture and food have used large amounts of chemicals, energy, pesticides and plastic. Novonesis's enzymes do the same work at lower temperatures with fewer chemicals, raise yields, and cut land, pesticide and food waste. The benefit appears for nature: over 80% of its sales and pipeline align with six SDGs.
Source nature: Novonesis / American Cleaning Institute / P1 First-party / independent (reporting). Positive effects are not used to offset negatives.
Positive / negative effects
+ effects
- The former Novozymes cut its own emissions 63% versus 2018, among the first companies in the world with an SBTi-validated net-zero target.P1 First-party / independent / Novonesis / SBTi
− effects (confirmed)
- No confirmed −.
- A listed, for-profit biotech
- the product plus (less chemistry / fewer resources) depends on how customers use it (indirect).
- Life-cycle verification of biosolutions' effect (less chemistry/resources); adoption in agriculture and food; reaching net zero; the quality of post-merger synergies.
A second look
The plus is an effect on nature—cutting chemicals, energy, pesticides and plastic, and food efficiency and biodiversity—through enzymes and microbes, backed by SBTi net-zero validation, a 63% emissions cut, and 80%+ of sales aligned to SDGs. But it is a listed, for-profit biotech, and the product plus (less chemistry, fewer resources) is indirect, depending on how customers use it. Weighing the genuine, large-scale biosolutions plus, B/high.
Sources
How to read this assessment
- Reachable upper bound (ceiling): a confirmed − sets the ceiling, and independently verified + decide the position within it. + do not cancel out −.
- The weight of evidence is not symmetric: only confirmed − are counted; the volume of disputes or allegations goes under “Watching.” + are counted from independent evidence, while an organization’s own PR is treated as “reference.”
- Size is not value: scale is not used in the assessment. Matters that stay within money or competition—investors, shareholders, sanctions, trade secrets—are also excluded.
- The letter (assessment) and certainty (how reliable the information is) are separate axes.
This is a translation; the Japanese version is authoritative. The assessments here are generated automatically by AI based on published criteria. The operator does not alter individual results. Because they are AI-generated they may contain errors, and they are opinion and commentary, not statements of fact. Where evidence is insufficient, the entry is marked “On hold.” Requests for correction are accepted via the form.
Terms: Narrative Value = an assessment (A–G) of the distance between the narrative an organization tells and its reality / Ceiling meter = a visualization of the reachable upper bound / Watching = unconfirmed matters not counted / Protected stakeholders = people, animals, nature, and future generations. | Generated by: AI | As of: 2026-Q3 | Back to top